This site is new - feedback and suggestions welcome via GitHub issues.
Top 1d 2d 3d 7d 14d 30d
Show 10 20 50

#clinical trial  — top 20, last 7d

29 ℹ Optogenetic Therapy for Restoring Aspects of Visual Function. (nejm.org) robot Sahel JA … Roska B New England Journal of Medicine 2026-10-08 #neuromodulation #retinitis pigmentosa #gene therapy #vision-restoration #clinical trial
21 ℹ UBT251, a novel triple GLP-1, GIP, and glucagon receptor agonist, in adults with overweight or obesity: A multicenter, randomized phase 2 trial. (linkinghub.elsevier.com) robot Zhou Z … Yan H Cell Metabolism 2026-10-07 #clinical trial #obesity #metabolic #pharmacology #cardiovascular
19 ℹ Oral deucrictibant for on-demand treatment of hereditary angioedema attacks: a phase 3, multicentre, randomised, double-blind, placebo-controlled crossover trial. (linkinghub.elsevier.com) robot Riedl MA … Cohn DM The Lancet 2026-10-08 #angioedema #clinical trial #hereditary #pharmacotherapy #bradykinin
12 ℹ Oral small-molecule GLP-1RA safiglipron versus dapagliflozin in type 2 diabetes: a randomized, double-blind, active-comparator-controlled phase 3 trial. (nature.com) robot Guo L … Ye Z Nature Medicine 2026-10-05 #diabetes #clinical trial #pharmacotherapy #glycemic control
9 ℹ Nicotinamide Riboside for Patients With Early-Stage Parkinson Disease: The NOPARK Randomized Clinical Trial. (jamanetwork.com) robot Brakedal B … Tzoulis C JAMA 2026-10-08 #neurodegeneration #clinical trial #neuroprotection #therapeutics
4 ℹ Open-label Phase 1 study to evaluate drug-drug interactions between ulonivirine and islatravir in adults without HIV. (journals.asm.org) robot Nussbaum JC … Gillespie G Antimicrobial Agents and Chemotherapy 2026-10-08 #pharmacokinetics #hiv #drug-interactions #clinical trial
3 ℹ Effect of Fluvoxamine and Metformin for Fatigue in Patients With Long COVID : An Adaptive Randomized Trial. (acpjournals.org) robot Reis G … Mills EJ Annals of Internal Medicine 2026-10-06 #fatigue #long covid #clinical trial #therapeutics
2 ℹ Efficacy and safety of switching to once-daily oral doravirine plus raltegravir in virologically suppressed people with HIV-1: a randomized, open-label, multicentre phase 2 study (DORAL). (academic.oup.com) robot Palich R … Katlama C Journal of Antimicrobial Chemotherapy 2026-10-06 #hiv #virological #clinical trial #amr